The Role of Surgery of the Primary Tumour With Few or Absent Symptoms in Patients With Synchronous Unresectable Metastases of Colon Cancer, a Randomized Phase III Study
Latest Information Update: 18 Sep 2023
Price :
$35 *
At a glance
- Drugs Antineoplastics (Primary) ; Bevacizumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 11 Sep 2023 Status changed from active, no longer recruiting to completed.
- 06 Jun 2023 Results presented at the 59th Annual Meeting of the American Society of Clinical Oncology
- 22 Jan 2021 Status changed from recruiting to active, no longer recruiting.